Clinical trial
Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients
NCT05004701 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 29, 2020
- Completion date
- November 10, 2022
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wilson's disease and covid-19